Avenir Wellness Solutions, Inc.
AVRW
$0.0331
$0.000.00%
| Weiss Ratings | AVRW - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Very Weak | |||
| Risk Grade | E+ | |||
| Reward Grade | E | |||
| Rating Factors | AVRW - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Weak | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Weak | |||
| Total Return Index | Very Weak | |||
| Volatility Index | Very Weak | |||
| Beta / Standard Deviation | AVRW - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.16 | |||
| Price History | AVRW - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 0.30% | |||
| 30-Day Total Return | 9.24% | |||
| 60-Day Total Return | -31.75% | |||
| 90-Day Total Return | -46.44% | |||
| Year to Date Total Return | -54.90% | |||
| 1-Year Total Return | -77.28% | |||
| 2-Year Total Return | -89.97% | |||
| 3-Year Total Return | -95.75% | |||
| 5-Year Total Return | -99.09% | |||
| 52-Week High % Change | -86.76% | |||
| 52-Week Low % Change | 46.46% | |||
| Price | AVRW - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $0.25 | |||
| 52-Week Low Price | $0.02 | |||
| 52-Week Low Price (Date) | Mar 04, 2024 | |||
| 52-Week High Price (Date) | Aug 11, 2023 | |||
| Valuation | AVRW - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 2.42M | |||
| Enterprise Value | 10.74M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -0.15 | |||
| Earnings Per Share Growth | -52.16% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 0.58 | |||
| Price/Book (Q) | -0.24 | |||
| Enterprise Value/Revenue (TTM) | 2.59 | |||
| Price | $0.03 | |||
| Enterprise Value/EBITDA (TTM) | -1.55 | |||
| Enterprise Value/EBIT | -1.52 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | AVRW - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 72.23M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | AVRW - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 424 273 8675 | |||
| Address | 5805 Sepulveda Blvd Sherman Oaks, CA 91411 | |||
| Website | www.avenirwellness.com | |||
| Country | United States | |||
| Year Founded | 2011 | |||
| Profitability | AVRW - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -171.26% | |||
| Profit Margin | -255.34% | |||
| Management Effectiveness | AVRW - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -49.81% | |||
| Return on Equity | -- | |||
| Income Statement | AVRW - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 4.14M | |||
| Total Revenue (TTM) | 4.14M | |||
| Revenue Per Share | $0.06 | |||
| Gross Profit (TTM) | 2.61M | |||
| EBITDA (TTM) | -6.95M | |||
| EBIT (TTM) | -7.09M | |||
| Net Income (TTM) | -10.57M | |||
| Net Income Avl. to Common (TTM) | -10.57M | |||
| Total Revenue Growth (Q YOY) | -43.11% | |||
| Earnings Growth (Q YOY) | 23.55% | |||
| EPS Diluted (TTM) | -0.15 | |||
| EPS Diluted Growth (Q YOY) | 39.37% | |||
| Balance Sheet | AVRW - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 189.00K | |||
| Cash Per Share (Q) | $0.00 | |||
| Total Current Assets (Q) | 1.98M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | -9.97M | |||
| Current Ratio (Q) | 0.155 | |||
| Book Value Per Share (Q) | -$0.14 | |||
| Total Assets (Q) | 2.82M | |||
| Total Current Liabilities (Q) | 12.79M | |||
| Total Debt (Q) | 8.50M | |||
| Total Liabilities (Q) | 12.79M | |||
| Total Common Equity (Q) | -9.97M | |||
| Cash Flow | AVRW - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | 645.00K | |||
| Cash from Financing (TTM) | 6.00K | |||
| Net Change in Cash (TTM) | -4.25M | |||
| Levered Free Cash Flow (TTM) | -1.58M | |||
| Cash from Operations (TTM) | -4.91M | |||
